{"id":361013,"date":"2025-08-30T16:12:34","date_gmt":"2025-08-30T16:12:34","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-lemaitre-vascular\/"},"modified":"2025-08-30T16:12:34","modified_gmt":"2025-08-30T16:12:34","slug":"how-to-buy-lemaitre-vascular","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/","title":{"rendered":"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-361013","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r - LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r - LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"LeMaitre Vascular, Inc. (LMAT) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejisi ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"LeMaitre Vascular, Inc. (LMAT) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejisi ile \u00f6\u011frenin."},"intro":"Ger\u00e7ekten uzuvlar\u0131 kurtaran bir medikal cihaz \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? LeMaitre Vascular, sa\u011fl\u0131k inovasyonunu sa\u011flam finansal performansla birle\u015ftiriyor. Son on y\u0131lda 180.000'den fazla baca\u011f\u0131 kurtarmaya yard\u0131mc\u0131 olan cihazlar\u0131yla, bu sadece ba\u015fka bir hisse senedi de\u011fil\u2014hayat de\u011fi\u015ftiren teknolojiye yap\u0131lan bir yat\u0131r\u0131md\u0131r. LMAT hisselerini sat\u0131n almak i\u00e7in bilmeniz gereken her \u015feyi birlikte inceleyelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Ger\u00e7ekten uzuvlar\u0131 kurtaran bir medikal cihaz \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? LeMaitre Vascular, sa\u011fl\u0131k inovasyonunu sa\u011flam finansal performansla birle\u015ftiriyor. Son on y\u0131lda 180.000'den fazla baca\u011f\u0131 kurtarmaya yard\u0131mc\u0131 olan cihazlar\u0131yla, bu sadece ba\u015fka bir hisse senedi de\u011fil\u2014hayat de\u011fi\u015ftiren teknolojiye yap\u0131lan bir yat\u0131r\u0131md\u0131r. LMAT hisselerini sat\u0131n almak i\u00e7in bilmeniz gereken her \u015feyi birlikte inceleyelim."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Noktas\u0131 Analizi<\/h2> <p>30 A\u011fustos 2025 itibar\u0131yla LeMaitre Vascular (LMAT), NASDAQ borsas\u0131nda <strong>97,60 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi 2025 boyunca \u00f6nemli dalgalanmalar ya\u015fad\u0131 ancak hem k\u0131sa vadeli yat\u0131r\u0131mc\u0131lar hem de uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip k\u0131lan g\u00fc\u00e7l\u00fc temel g\u00f6stergeler sergiliyor.<\/p> <p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131:<\/strong> Takviminize <strong>30 Ekim 2025<\/strong> tarihini i\u015faretleyin\u2014LeMaitre bu tarihte 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar fiyatlarda dramatik hareketlere neden olmu\u015ftur. 5 A\u011fustos 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131na bak\u0131ld\u0131\u011f\u0131nda, hisse senedi hem gelir hem de kazan\u00e7 tahminlerini a\u015farak olumlu tepki verdi; gelir 63,15 milyon $ (y\u0131ll\u0131k %15 b\u00fcy\u00fcme) ve hisse ba\u015f\u0131na kazan\u00e7 (EPS) 0,60 $ ile konsensusu 0,03 $ a\u015ft\u0131<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127837\/10507\/en\/LeMaitre-Q2-2025-Financial-Results.html\">(2025 2. \u00c7eyrek Sonu\u00e7lar\u0131)<\/a>.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca Tarihsel Kazan\u00e7lar\u0131n Etki Analizi<\/h2> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><th>S\u00fcre<\/th><\/tr> <\/thead> <tbody> <tr><td>5 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>~92,00 $<\/td><td>%6,1 Art\u0131\u015f (1 hafta)<\/td><td>H\u0131zl\u0131 y\u00fckseli\u015f<\/td><\/tr> <tr><td>1 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>~88,50 $<\/td><td>%4,8 Art\u0131\u015f (3 g\u00fcn)<\/td><td>\u0130stikrarl\u0131 t\u0131rman\u0131\u015f<\/td><\/tr> <tr><td>\u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>~95,00 $<\/td><td>%3,2 D\u00fc\u015f\u00fc\u015f (beklentinin alt\u0131nda)<\/td><td>K\u0131sa s\u00fcreli d\u00fc\u015f\u00fc\u015f<\/td><\/tr> <tr><td>Kas 2024<\/td><td>\u00dcr\u00fcn Lansman\u0131<\/td><td>~89,00 $<\/td><td>%7,6 Art\u0131\u015f<\/td><td>S\u00fcrekli b\u00fcy\u00fcme<\/td><\/tr> <tr><td>A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>~86,00 $<\/td><td>%4,1 D\u00fc\u015f\u00fc\u015f<\/td><td>\u0130yile\u015fme gerekli<\/td><\/tr> <tr><td>May 2024<\/td><td>Y\u00f6nlendirme G\u00fcncellemesi<\/td><td>~83,00 $<\/td><td>%9,2 Art\u0131\u015f<\/td><td>G\u00fc\u00e7l\u00fc momentum<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc:<\/strong> Pozitif kazan\u00e7 s\u00fcrprizleri genellikle birka\u00e7 g\u00fcn i\u00e7inde %5-8 kazan\u00e7 sa\u011flarken, beklentilerin alt\u0131nda kalan sonu\u00e7lar ge\u00e7ici %3-5 d\u00fc\u015f\u00fc\u015flere yol a\u00e7ar ve g\u00fc\u00e7l\u00fc temel g\u00f6stergeler nedeniyle haftalar i\u00e7inde toparlan\u0131r.<\/p>  <h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Seyri ve Volatilite Deseni<\/h2> <p>LeMaitre hisseleri Mart'tan A\u011fustos 2025'e kadar bir h\u0131z treni yolculu\u011fu yapt\u0131:<\/p> <p><strong>Ocak-Mart 2025:<\/strong> Hisse senedi 102 $ civar\u0131nda g\u00fc\u00e7l\u00fc ba\u015flad\u0131 ancak Mart ay\u0131nda %8,66 d\u00fc\u015f\u00fc\u015fle 78,79 $ civar\u0131na geriledi<a href=\"https:\/\/stockscan.io\/stocks\/LMAT\/price-history\">(Fiyat Ge\u00e7mi\u015fi Verisi)<\/a>.<\/p> <p><strong>Nisan \u0130yile\u015fmesi:<\/strong> %8,15'lik bir toparlanma g\u00f6sterdi, ancak bu d\u00f6nemde 52 haftal\u0131k en d\u00fc\u015f\u00fck seviye olan 71,42 $'a dokundu.<\/p> <p><strong>May\u0131s Zorluklar\u0131:<\/strong> G\u00fc\u00e7l\u00fc temellere ra\u011fmen %9,41'lik ba\u015fka bir d\u00fc\u015f\u00fc\u015f ya\u015fand\u0131.<\/p> <p><strong>Yaz D\u00f6nemi \u0130stikrar\u0131:<\/strong> Haziran (%1,03) ve Temmuz (%1,61) gerekli istikrar\u0131 sa\u011flad\u0131 ve mevcut 97,60 $ seviyesine zemin haz\u0131rlad\u0131.<\/p> <p><strong>Volatilitenin sebebi nedir?<\/strong> Medikal cihaz hisseleri genellikle d\u00fczenleyici belirsizlikler ve prosed\u00fcr hacmi dalgalanmalar\u0131yla kar\u015f\u0131la\u015f\u0131r, ancak LeMaitre'nin tutarl\u0131 gelir b\u00fcy\u00fcmesi (%15 Y\u0131ll\u0131k) ve geni\u015fleyen k\u00fcresel varl\u0131\u011f\u0131 sa\u011flam temeller sunar.<\/p>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p><strong>2025 Y\u0131l Sonu:<\/strong> 105-115 $ (g\u00fc\u00e7l\u00fc tatil \u00e7eyre\u011fi + Avrupa Artegraft lansman\u0131) \u2192 <strong>AL<\/strong><br\/> <a href=\"https:\/\/stockanalysis.com\/stocks\/lmat\/forecast\/\">(Analist Konsens\u00fcs\u00fc)<\/a><\/p> <p><strong>2026 Projeksiyonu:<\/strong> 125-140 $ (tam y\u0131l uluslararas\u0131 geni\u015fleme faydalar\u0131 + yeni \u00fcr\u00fcn hatt\u0131)<\/p> <p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 160-190 $ (vask\u00fcler cihazlarda pazar liderli\u011fi + ya\u015flanan n\u00fcfus talebi)<\/p> <p><strong>2030 Vizyonu:<\/strong> 220-260 $ (k\u00fcresel sa\u011fl\u0131k altyap\u0131s\u0131 b\u00fcy\u00fcmesi + teknolojik inovasyon)<\/p> <p><strong>Karar:<\/strong> Y\u00f6netilebilir k\u0131sa vadeli volatilite ile m\u00fckemmel uzun vadeli tutma potansiyeli. Mevcut fiyat sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir giri\u015f sunuyor.<\/p>  <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici engeller:<\/strong> Medikal cihaz onaylar\u0131 \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir<\/li> <li><strong>Uluslararas\u0131 maruz kalma:<\/strong> Gelirin %45'i yurtd\u0131\u015f\u0131 piyasalardan geldi\u011fi i\u00e7in d\u00f6viz riski bulunuyor<\/li> <li><strong>Prosed\u00fcr hacimleri:<\/strong> Se\u00e7meli vask\u00fcler cerrahiler ekonomik durgunluklarda azalabilir<\/li> <li><strong>Rekabet:<\/strong> Daha b\u00fcy\u00fck medtech \u015firketleri rakip teknolojiler geli\u015ftirebilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Gelir b\u00fcy\u00fcmesi:<\/strong> %15 Y\u0131ll\u0131k b\u00fcy\u00fcme g\u00fc\u00e7l\u00fc uygulamay\u0131 g\u00f6steriyor<\/li> <li><strong>Avrupa geni\u015flemesi:<\/strong> Artegraft CE Mark onay\u0131 500M$+ pazar a\u00e7\u0131yor<\/li> <li><strong>Nakit pozisyonu:<\/strong> 319,5 milyon $ stratejik esneklik sa\u011fl\u0131yor<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131:<\/strong> Ya\u015flanan n\u00fcfus vask\u00fcler prosed\u00fcr talebini art\u0131r\u0131yor<\/li> <li><strong>\u00dcr\u00fcn inovasyonu:<\/strong> Valvulotom cihazlar\u0131 hayat kurtar\u0131c\u0131 etkisini kan\u0131tlad\u0131<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n:<\/strong> Portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10'unu ay\u0131rarak ba\u015flay\u0131n<\/li> <li><strong>Dolar maliyet ortalamas\u0131 yap\u0131n:<\/strong> Zamanlama riskini azaltmak i\u00e7in ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun:<\/strong> Potansiyel giri\u015f noktalar\u0131 i\u00e7in 30 Ekim'i yak\u0131ndan takip edin<\/li> <li><strong>Teknikleri izleyin:<\/strong> 90 $ g\u00fc\u00e7l\u00fc destek; 105 $ \u00fczeri k\u0131r\u0131l\u0131m momentum sinyali verir<\/li> <\/ol> <p><em>Mizahi deneyimli tavsiye:<\/em> \"LMAT ticareti yapmak vask\u00fcler cerrahi gibidir\u2014sakin eller g\u00f6steri\u015fli hareketlerden daha iyidir. Kahraman olmaya \u00e7al\u0131\u015fma; sadece hastan\u0131n (portf\u00f6y\u00fcn\u00fcn) istikrarl\u0131 iyile\u015fmesine yard\u0131m et!\"<\/p>  <h2>\u2705 LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul \u00fccretler sa\u011flay\u0131n<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Rahat edece\u011finiz bir risk miktar\u0131 ile ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"LMAT\" sembol\u00fcn\u00fc aray\u0131n<\/td><td>Do\u011fru g\u00fcvenlik i\u00e7in tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emirleri fiyat s\u00fcrprizlerini \u00f6nler<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Miktar ve fiyat\u0131 \u00e7ift kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu izleyin<\/td><td>Kazan\u00e7 ve haberler i\u00e7in uyar\u0131lar kurun<\/td><\/tr> <tr><td>7<\/td><td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td><td>K\u00e2r alma ve zarar durdurma seviyelerini belirleyin<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Pocket Option Medikal Cihaz Yat\u0131r\u0131mlar\u0131nda Neden \u00d6ne \u00c7\u0131k\u0131yor?<\/h2> <p>Pocket Option, LeMaitre Vascular gibi \u00f6zel hisselere yat\u0131r\u0131m i\u00e7in benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito: 5 $<\/strong> - Medikal cihaz hisseleriyle stratejileri \u00f6nemli risk olmadan test etmek i\u00e7in m\u00fckemmel<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> - Tek belge KYC s\u00fcreci ile dakikalar i\u00e7inde ticarete ba\u015flay\u0131n, g\u00fcnler de\u011fil<\/li> <li><strong>K\u00fcresel eri\u015fim<\/strong> - NASDAQ hisselerini her yerden y\u00fczlerce \u00e7ekim se\u00e7ene\u011fiyle al\u0131p sat\u0131n<\/li> <li><strong>E\u011fitim kaynaklar\u0131<\/strong> - <a href=\"\/blog\">Pocket Option blogu<\/a> s\u00fcrekli piyasa i\u00e7g\u00f6r\u00fcleri ve sekt\u00f6r analizleri sa\u011flar<\/li> <\/ul>  <h2>\ud83c\udf0d 2025'te LeMaitre Vascular: Uzuvlar\u0131 Kurtarmak, De\u011fer Yaratmak<\/h2> <p>LeMaitre Vascular, vask\u00fcler cerrahi cihazlar\u0131nda uzmanla\u015fm\u0131\u015f lider olarak 90'dan fazla \u00fclkede 160'tan fazla sat\u0131\u015f temsilcisiyle faaliyet g\u00f6stermektedir. \u015eirketin valvulotomlar ve biyolojik greftler gibi yenilik\u00e7i \u00e7\u00f6z\u00fcmlere odaklanmas\u0131, kritik sa\u011fl\u0131k ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131larken hissedar de\u011ferini art\u0131rmaktad\u0131r.<\/p> <p><strong>G\u00fcncel piyasa konumu:<\/strong> 2,15 milyar $ piyasa de\u011feri, g\u00fc\u00e7l\u00fc bilan\u00e7o (319,5M $ nakit) ve d\u00fczenli temett\u00fc \u00f6demeleri (\u00e7eyreklik 0,20 $)<\/p> <p><strong>B\u00fcy\u00fcme fakt\u00f6rleri:<\/strong> \u00d6zellikle Artegraft'\u0131n CE Mark onay\u0131ndan sonra Avrupa'da geni\u015fleyen uluslararas\u0131 varl\u0131k ve minimal invaziv vask\u00fcler prosed\u00fcrlerde devam eden \u00fcr\u00fcn inovasyonu<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek:<\/strong> LeMaitre cihazlar\u0131 son on y\u0131lda 180.000'den fazla baca\u011f\u0131n kurtar\u0131lmas\u0131na katk\u0131da bulundu\u2014bu, orta b\u00fcy\u00fckl\u00fckte bir \u015fehirdeki herkesin hareket kabiliyetini kaybetmesini \u00f6nlemek gibi bir \u015fey!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Noktas\u0131 Analizi<\/h2>\n<p>30 A\u011fustos 2025 itibar\u0131yla LeMaitre Vascular (LMAT), NASDAQ borsas\u0131nda <strong>97,60 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi 2025 boyunca \u00f6nemli dalgalanmalar ya\u015fad\u0131 ancak hem k\u0131sa vadeli yat\u0131r\u0131mc\u0131lar hem de uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip k\u0131lan g\u00fc\u00e7l\u00fc temel g\u00f6stergeler sergiliyor.<\/p>\n<p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131:<\/strong> Takviminize <strong>30 Ekim 2025<\/strong> tarihini i\u015faretleyin\u2014LeMaitre bu tarihte 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar fiyatlarda dramatik hareketlere neden olmu\u015ftur. 5 A\u011fustos 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131na bak\u0131ld\u0131\u011f\u0131nda, hisse senedi hem gelir hem de kazan\u00e7 tahminlerini a\u015farak olumlu tepki verdi; gelir 63,15 milyon $ (y\u0131ll\u0131k %15 b\u00fcy\u00fcme) ve hisse ba\u015f\u0131na kazan\u00e7 (EPS) 0,60 $ ile konsensusu 0,03 $ a\u015ft\u0131<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127837\/10507\/en\/LeMaitre-Q2-2025-Financial-Results.html\">(2025 2. \u00c7eyrek Sonu\u00e7lar\u0131)<\/a>.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca Tarihsel Kazan\u00e7lar\u0131n Etki Analizi<\/h2>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<th>S\u00fcre<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>5 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>~92,00 $<\/td>\n<td>%6,1 Art\u0131\u015f (1 hafta)<\/td>\n<td>H\u0131zl\u0131 y\u00fckseli\u015f<\/td>\n<\/tr>\n<tr>\n<td>1 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>~88,50 $<\/td>\n<td>%4,8 Art\u0131\u015f (3 g\u00fcn)<\/td>\n<td>\u0130stikrarl\u0131 t\u0131rman\u0131\u015f<\/td>\n<\/tr>\n<tr>\n<td>\u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>~95,00 $<\/td>\n<td>%3,2 D\u00fc\u015f\u00fc\u015f (beklentinin alt\u0131nda)<\/td>\n<td>K\u0131sa s\u00fcreli d\u00fc\u015f\u00fc\u015f<\/td>\n<\/tr>\n<tr>\n<td>Kas 2024<\/td>\n<td>\u00dcr\u00fcn Lansman\u0131<\/td>\n<td>~89,00 $<\/td>\n<td>%7,6 Art\u0131\u015f<\/td>\n<td>S\u00fcrekli b\u00fcy\u00fcme<\/td>\n<\/tr>\n<tr>\n<td>A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>~86,00 $<\/td>\n<td>%4,1 D\u00fc\u015f\u00fc\u015f<\/td>\n<td>\u0130yile\u015fme gerekli<\/td>\n<\/tr>\n<tr>\n<td>May 2024<\/td>\n<td>Y\u00f6nlendirme G\u00fcncellemesi<\/td>\n<td>~83,00 $<\/td>\n<td>%9,2 Art\u0131\u015f<\/td>\n<td>G\u00fc\u00e7l\u00fc momentum<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc:<\/strong> Pozitif kazan\u00e7 s\u00fcrprizleri genellikle birka\u00e7 g\u00fcn i\u00e7inde %5-8 kazan\u00e7 sa\u011flarken, beklentilerin alt\u0131nda kalan sonu\u00e7lar ge\u00e7ici %3-5 d\u00fc\u015f\u00fc\u015flere yol a\u00e7ar ve g\u00fc\u00e7l\u00fc temel g\u00f6stergeler nedeniyle haftalar i\u00e7inde toparlan\u0131r.<\/p>\n<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Seyri ve Volatilite Deseni<\/h2>\n<p>LeMaitre hisseleri Mart&#8217;tan A\u011fustos 2025&#8217;e kadar bir h\u0131z treni yolculu\u011fu yapt\u0131:<\/p>\n<p><strong>Ocak-Mart 2025:<\/strong> Hisse senedi 102 $ civar\u0131nda g\u00fc\u00e7l\u00fc ba\u015flad\u0131 ancak Mart ay\u0131nda %8,66 d\u00fc\u015f\u00fc\u015fle 78,79 $ civar\u0131na geriledi<a href=\"https:\/\/stockscan.io\/stocks\/LMAT\/price-history\">(Fiyat Ge\u00e7mi\u015fi Verisi)<\/a>.<\/p>\n<p><strong>Nisan \u0130yile\u015fmesi:<\/strong> %8,15&#8217;lik bir toparlanma g\u00f6sterdi, ancak bu d\u00f6nemde 52 haftal\u0131k en d\u00fc\u015f\u00fck seviye olan 71,42 $&#8217;a dokundu.<\/p>\n<p><strong>May\u0131s Zorluklar\u0131:<\/strong> G\u00fc\u00e7l\u00fc temellere ra\u011fmen %9,41&#8217;lik ba\u015fka bir d\u00fc\u015f\u00fc\u015f ya\u015fand\u0131.<\/p>\n<p><strong>Yaz D\u00f6nemi \u0130stikrar\u0131:<\/strong> Haziran (%1,03) ve Temmuz (%1,61) gerekli istikrar\u0131 sa\u011flad\u0131 ve mevcut 97,60 $ seviyesine zemin haz\u0131rlad\u0131.<\/p>\n<p><strong>Volatilitenin sebebi nedir?<\/strong> Medikal cihaz hisseleri genellikle d\u00fczenleyici belirsizlikler ve prosed\u00fcr hacmi dalgalanmalar\u0131yla kar\u015f\u0131la\u015f\u0131r, ancak LeMaitre&#8217;nin tutarl\u0131 gelir b\u00fcy\u00fcmesi (%15 Y\u0131ll\u0131k) ve geni\u015fleyen k\u00fcresel varl\u0131\u011f\u0131 sa\u011flam temeller sunar.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p><strong>2025 Y\u0131l Sonu:<\/strong> 105-115 $ (g\u00fc\u00e7l\u00fc tatil \u00e7eyre\u011fi + Avrupa Artegraft lansman\u0131) \u2192 <strong>AL<\/strong><br \/> <a href=\"https:\/\/stockanalysis.com\/stocks\/lmat\/forecast\/\">(Analist Konsens\u00fcs\u00fc)<\/a><\/p>\n<p><strong>2026 Projeksiyonu:<\/strong> 125-140 $ (tam y\u0131l uluslararas\u0131 geni\u015fleme faydalar\u0131 + yeni \u00fcr\u00fcn hatt\u0131)<\/p>\n<p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 160-190 $ (vask\u00fcler cihazlarda pazar liderli\u011fi + ya\u015flanan n\u00fcfus talebi)<\/p>\n<p><strong>2030 Vizyonu:<\/strong> 220-260 $ (k\u00fcresel sa\u011fl\u0131k altyap\u0131s\u0131 b\u00fcy\u00fcmesi + teknolojik inovasyon)<\/p>\n<p><strong>Karar:<\/strong> Y\u00f6netilebilir k\u0131sa vadeli volatilite ile m\u00fckemmel uzun vadeli tutma potansiyeli. Mevcut fiyat sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir giri\u015f sunuyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici engeller:<\/strong> Medikal cihaz onaylar\u0131 \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir<\/li>\n<li><strong>Uluslararas\u0131 maruz kalma:<\/strong> Gelirin %45&#8217;i yurtd\u0131\u015f\u0131 piyasalardan geldi\u011fi i\u00e7in d\u00f6viz riski bulunuyor<\/li>\n<li><strong>Prosed\u00fcr hacimleri:<\/strong> Se\u00e7meli vask\u00fcler cerrahiler ekonomik durgunluklarda azalabilir<\/li>\n<li><strong>Rekabet:<\/strong> Daha b\u00fcy\u00fck medtech \u015firketleri rakip teknolojiler geli\u015ftirebilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Gelir b\u00fcy\u00fcmesi:<\/strong> %15 Y\u0131ll\u0131k b\u00fcy\u00fcme g\u00fc\u00e7l\u00fc uygulamay\u0131 g\u00f6steriyor<\/li>\n<li><strong>Avrupa geni\u015flemesi:<\/strong> Artegraft CE Mark onay\u0131 500M$+ pazar a\u00e7\u0131yor<\/li>\n<li><strong>Nakit pozisyonu:<\/strong> 319,5 milyon $ stratejik esneklik sa\u011fl\u0131yor<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131:<\/strong> Ya\u015flanan n\u00fcfus vask\u00fcler prosed\u00fcr talebini art\u0131r\u0131yor<\/li>\n<li><strong>\u00dcr\u00fcn inovasyonu:<\/strong> Valvulotom cihazlar\u0131 hayat kurtar\u0131c\u0131 etkisini kan\u0131tlad\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n:<\/strong> Portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10&#8217;unu ay\u0131rarak ba\u015flay\u0131n<\/li>\n<li><strong>Dolar maliyet ortalamas\u0131 yap\u0131n:<\/strong> Zamanlama riskini azaltmak i\u00e7in ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun:<\/strong> Potansiyel giri\u015f noktalar\u0131 i\u00e7in 30 Ekim&#8217;i yak\u0131ndan takip edin<\/li>\n<li><strong>Teknikleri izleyin:<\/strong> 90 $ g\u00fc\u00e7l\u00fc destek; 105 $ \u00fczeri k\u0131r\u0131l\u0131m momentum sinyali verir<\/li>\n<\/ol>\n<p><em>Mizahi deneyimli tavsiye:<\/em> &#8220;LMAT ticareti yapmak vask\u00fcler cerrahi gibidir\u2014sakin eller g\u00f6steri\u015fli hareketlerden daha iyidir. Kahraman olmaya \u00e7al\u0131\u015fma; sadece hastan\u0131n (portf\u00f6y\u00fcn\u00fcn) istikrarl\u0131 iyile\u015fmesine yard\u0131m et!&#8221;<\/p>\n<h2>\u2705 LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul \u00fccretler sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Rahat edece\u011finiz bir risk miktar\u0131 ile ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;LMAT&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>Do\u011fru g\u00fcvenlik i\u00e7in tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri fiyat s\u00fcrprizlerini \u00f6nler<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Miktar ve fiyat\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Kazan\u00e7 ve haberler i\u00e7in uyar\u0131lar kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td>\n<td>K\u00e2r alma ve zarar durdurma seviyelerini belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Medikal Cihaz Yat\u0131r\u0131mlar\u0131nda Neden \u00d6ne \u00c7\u0131k\u0131yor?<\/h2>\n<p>Pocket Option, LeMaitre Vascular gibi \u00f6zel hisselere yat\u0131r\u0131m i\u00e7in benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito: 5 $<\/strong> &#8211; Medikal cihaz hisseleriyle stratejileri \u00f6nemli risk olmadan test etmek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> &#8211; Tek belge KYC s\u00fcreci ile dakikalar i\u00e7inde ticarete ba\u015flay\u0131n, g\u00fcnler de\u011fil<\/li>\n<li><strong>K\u00fcresel eri\u015fim<\/strong> &#8211; NASDAQ hisselerini her yerden y\u00fczlerce \u00e7ekim se\u00e7ene\u011fiyle al\u0131p sat\u0131n<\/li>\n<li><strong>E\u011fitim kaynaklar\u0131<\/strong> &#8211; <a href=\"\/blog\">Pocket Option blogu<\/a> s\u00fcrekli piyasa i\u00e7g\u00f6r\u00fcleri ve sekt\u00f6r analizleri sa\u011flar<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te LeMaitre Vascular: Uzuvlar\u0131 Kurtarmak, De\u011fer Yaratmak<\/h2>\n<p>LeMaitre Vascular, vask\u00fcler cerrahi cihazlar\u0131nda uzmanla\u015fm\u0131\u015f lider olarak 90&#8217;dan fazla \u00fclkede 160&#8217;tan fazla sat\u0131\u015f temsilcisiyle faaliyet g\u00f6stermektedir. \u015eirketin valvulotomlar ve biyolojik greftler gibi yenilik\u00e7i \u00e7\u00f6z\u00fcmlere odaklanmas\u0131, kritik sa\u011fl\u0131k ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131larken hissedar de\u011ferini art\u0131rmaktad\u0131r.<\/p>\n<p><strong>G\u00fcncel piyasa konumu:<\/strong> 2,15 milyar $ piyasa de\u011feri, g\u00fc\u00e7l\u00fc bilan\u00e7o (319,5M $ nakit) ve d\u00fczenli temett\u00fc \u00f6demeleri (\u00e7eyreklik 0,20 $)<\/p>\n<p><strong>B\u00fcy\u00fcme fakt\u00f6rleri:<\/strong> \u00d6zellikle Artegraft&#8217;\u0131n CE Mark onay\u0131ndan sonra Avrupa&#8217;da geni\u015fleyen uluslararas\u0131 varl\u0131k ve minimal invaziv vask\u00fcler prosed\u00fcrlerde devam eden \u00fcr\u00fcn inovasyonu<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek:<\/strong> LeMaitre cihazlar\u0131 son on y\u0131lda 180.000&#8217;den fazla baca\u011f\u0131n kurtar\u0131lmas\u0131na katk\u0131da bulundu\u2014bu, orta b\u00fcy\u00fckl\u00fckte bir \u015fehirdeki herkesin hareket kabiliyetini kaybetmesini \u00f6nlemek gibi bir \u015fey!<\/p>\n"},"faq":[{"question":"LeMaitre Vascular hisseleri nereden al\u0131nabilir?","answer":"LeMaitre Vascular hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve g\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"LMAT hisseleri i\u00e7in en iyi yat\u0131r\u0131m stratejisi nedir?","answer":"Yeni ba\u015flayanlar i\u00e7in k\u00fc\u00e7\u00fck yat\u0131r\u0131mlarla ba\u015flamak, dolar maliyet ortalamas\u0131 yapmak ve \u00f6nemli kazan\u00e7 a\u00e7\u0131klamalar\u0131n\u0131 takip etmek \u00f6nerilir."},{"question":"LeMaitre Vascular'\u0131n b\u00fcy\u00fcme potansiyeli nedir?","answer":"\u015eirket, %15 y\u0131ll\u0131k gelir b\u00fcy\u00fcmesi, Avrupa geni\u015flemesi ve yenilik\u00e7i \u00fcr\u00fcnleri ile g\u00fc\u00e7l\u00fc bir uzun vadeli b\u00fcy\u00fcme potansiyeline sahiptir."},{"question":"LeMaitre Vascular hisselerinde hangi riskler bulunmaktad\u0131r?","answer":"D\u00fczenleyici onay gecikmeleri, d\u00f6viz kuru riski, ekonomik dalgalanmalarda prosed\u00fcr hacmi d\u00fc\u015f\u00fc\u015f\u00fc ve rekabet \u00f6nemli riskler aras\u0131ndad\u0131r."},{"question":"Pocket Option neden medikal cihaz hisseleri i\u00e7in iyi bir platformdur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, k\u00fcresel eri\u015fim ve kapsaml\u0131 e\u011fitim kaynaklar\u0131 ile yat\u0131r\u0131mc\u0131lar i\u00e7in avantajlar sunar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"LeMaitre Vascular hisseleri nereden al\u0131nabilir?","answer":"LeMaitre Vascular hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve g\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"LMAT hisseleri i\u00e7in en iyi yat\u0131r\u0131m stratejisi nedir?","answer":"Yeni ba\u015flayanlar i\u00e7in k\u00fc\u00e7\u00fck yat\u0131r\u0131mlarla ba\u015flamak, dolar maliyet ortalamas\u0131 yapmak ve \u00f6nemli kazan\u00e7 a\u00e7\u0131klamalar\u0131n\u0131 takip etmek \u00f6nerilir."},{"question":"LeMaitre Vascular'\u0131n b\u00fcy\u00fcme potansiyeli nedir?","answer":"\u015eirket, %15 y\u0131ll\u0131k gelir b\u00fcy\u00fcmesi, Avrupa geni\u015flemesi ve yenilik\u00e7i \u00fcr\u00fcnleri ile g\u00fc\u00e7l\u00fc bir uzun vadeli b\u00fcy\u00fcme potansiyeline sahiptir."},{"question":"LeMaitre Vascular hisselerinde hangi riskler bulunmaktad\u0131r?","answer":"D\u00fczenleyici onay gecikmeleri, d\u00f6viz kuru riski, ekonomik dalgalanmalarda prosed\u00fcr hacmi d\u00fc\u015f\u00fc\u015f\u00fc ve rekabet \u00f6nemli riskler aras\u0131ndad\u0131r."},{"question":"Pocket Option neden medikal cihaz hisseleri i\u00e7in iyi bir platformdur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, k\u00fcresel eri\u015fim ve kapsaml\u0131 e\u011fitim kaynaklar\u0131 ile yat\u0131r\u0131mc\u0131lar i\u00e7in avantajlar sunar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r - LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r - LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T16:12:34+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-30T16:12:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/\",\"name\":\"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r - LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-30T16:12:34+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r - LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/","og_locale":"tr_TR","og_type":"article","og_title":"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r - LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T16:12:34+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-30T16:12:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/","name":"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r - LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-30T16:12:34+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lemaitre-vascular\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"LeMaitre Vascular, Inc. (LMAT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LeMaitre Vascular, Inc. (LMAT) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":361018,"slug":"how-to-buy-lemaitre-vascular","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu LeMaitre Vascular, Inc. (LMAT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu LeMaitre Vascular, Inc. (LMAT)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-lemaitre-vascular\/"},"pt_AA":{"locale":"pt_AA","id":361017,"slug":"how-to-buy-lemaitre-vascular","post_title":"Como comprar a\u00e7\u00f5es da LeMaitre Vascular, Inc. (LMAT) - Investimento em a\u00e7\u00f5es da LeMaitre Vascular, Inc. (LMAT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-lemaitre-vascular\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/361013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=361013"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/361013\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=361013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=361013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=361013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}